Dual effects of an anti-CD147 antibody for Esophageal cancer therapy
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Dual effects of an anti-CD147 antibody for Esophageal cancer therapy
Authors
Keywords
-
Journal
CANCER BIOLOGY & THERAPY
Volume -, Issue -, Pages 1-10
Publisher
Informa UK Limited
Online
2019-08-14
DOI
10.1080/15384047.2019.1647052
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Technical feasibility of endoscopic submucosal dissection for local failure after chemoradiotherapy or radiotherapy for esophageal squamous cell carcinoma
- (2018) Keiichiro Nakajo et al. GASTROINTESTINAL ENDOSCOPY
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2018) Freddie Bray et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Diesel exhaust particles induce autophagy and citrullination in Normal Human Bronchial Epithelial cells
- (2018) Tania Colasanti et al. Cell Death & Disease
- Up-regulated basigin-2 in microglia induced by hypoxia promotes retinal angiogenesis
- (2017) Jie Yin et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- The prognostic and clinicopathologic characteristics of CD147 and esophagus cancer: A meta-analysis
- (2017) Hui Li et al. PLoS One
- Overexpression of CD147 is associated with poor prognosis, tumor cell migration and ERK signaling pathway activation in hepatocellular carcinoma
- (2017) Wenjing Xiao et al. Experimental and Therapeutic Medicine
- Recent Advances From Basic and Clinical Studies of Esophageal Squamous Cell Carcinoma
- (2015) Shinya Ohashi et al. GASTROENTEROLOGY
- CD147 reprograms fatty acid metabolism in hepatocellular carcinoma cells through Akt/mTOR/SREBP1c and P38/PPARα pathways
- (2015) Jibin Li et al. JOURNAL OF HEPATOLOGY
- Advances in targeted therapies and new promising targets in esophageal cancer
- (2015) Abbes Belkhiri et al. Oncotarget
- Ramucirumab plus paclitaxel versus placebo plus paclitaxel in patients with previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (RAINBOW): a double-blind, randomised phase 3 trial
- (2014) Hansjochen Wilke et al. LANCET ONCOLOGY
- CD147 in Ovarian and Other Cancers
- (2012) Hong Yang et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Clinical Impact of HAb18G/CD147 Expression in Esophageal Squamous Cell Carcinoma
- (2011) Shaojun Zhu et al. DIGESTIVE DISEASES AND SCIENCES
- Advances in the assessment and control of the effector functions of therapeutic antibodies
- (2011) Xu-Rong Jiang et al. NATURE REVIEWS DRUG DISCOVERY
- Rituximab: Mechanism of Action
- (2010) George J. Weiner SEMINARS IN HEMATOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now